EPIRUS Biopharmaceuticals, Inc. - FORM 10-Q - EX-32.1 - CERTIFICATION OF CEO & CFO PURSUANT TO SECTION 906 - May 5, 2011

Attached files

file filename
10-Q - FORM 10-Q - EPIRUS Biopharmaceuticals, Inc.d10q.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 - EPIRUS Biopharmaceuticals, Inc.dex312.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 - EPIRUS Biopharmaceuticals, Inc.dex311.htm
EX-10.25 - THE REGISTRANT'S FORM STOCK OPTION AGREEMENT - EPIRUS Biopharmaceuticals, Inc.dex1025.htm
EX-10.24 - THE REGISTRANT'S FORM STOCK OPTION AGREEMENT - EPIRUS Biopharmaceuticals, Inc.dex1024.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as principal executive officer and principal financial officer of Zalicus Inc. (the “Company”), do hereby certify that to their knowledge:

 

  1) the Company’s Form 10-Q for the fiscal quarter ended March 31, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2) the information contained in the Company’s Form 10-Q for the fiscal quarter ended March 31, 2011 fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Mark H. N. Corrigan

Mark H. N. Corrigan

President and Chief Executive Officer

(principal executive officer)

 

/s/ Justin A. Renz

Justin A. Renz

Senior Vice President and Chief Financial Officer

(principal financial officer)

Dated: May 5, 2011

Stock widget

Investing forum

EPIRUS Biopharmaceuticals, Inc. Reports